ONCOdianova - The Future of Biomarkes - TIGIT / CD112R / CALRmut. ONCOdianova‘s antibody development program concentrates on the tissue-based detection of cancer immunology checkpoint biomarkers. Our vision is to provide the best primary antibodies for combined use in multiplex IHC panels.
Category: Business & Industrial
City: Hamburg
State: Hamburg
Country: Germany (DE)
Platform: WooCommerce
Technologies used: Google Ads Pixel, Google Adsense, Google Tag Manager, Yoast
Contact page: https://www.oncodianova.com/contact
Signup for Free. No Credit Card required.Suitable for marketing agencies, app developers and new business ideas.
No credit card required.